143 related articles for article (PubMed ID: 4026377)
1. Mast cells and macrophages in early relapsing psoriasis.
Schubert C; Christophers E
Arch Dermatol Res; 1985; 277(5):352-8. PubMed ID: 4026377
[TBL] [Abstract][Full Text] [Related]
2. Mast cell alterations in chronic psoriasis vulgaris: response to low-strength anthralin treatment. A transmission electron microscopic study.
Brody I
Ups J Med Sci; 1986; 91(1):1-16. PubMed ID: 3716018
[TBL] [Abstract][Full Text] [Related]
3. Dermal and epidermal involvement in the evolution of acute eruptive guttate psoriasis vulgaris.
Brody I
J Invest Dermatol; 1984 May; 82(5):465-70. PubMed ID: 6512270
[TBL] [Abstract][Full Text] [Related]
4. The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis.
Castelijns FA; Gerritsen MJ; van Vlijmen-Willems IM; van Erp PE; van de Kerkhof PC
J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):901-9. PubMed ID: 10365920
[TBL] [Abstract][Full Text] [Related]
5. Mast cell density in psoriatic skin. The effect of PUVA and corticosteroid therapy.
Töyry S; Fräki J; Tammi R
Arch Dermatol Res; 1988; 280(5):282-5. PubMed ID: 3178285
[TBL] [Abstract][Full Text] [Related]
6. The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.
Swinkels OQ; Prins M; Tosserams EF; Gerritsen MJ; Van Der Valk PG; Van De Kerkhof PC
Br J Dermatol; 2001 Jul; 145(1):63-9. PubMed ID: 11453908
[TBL] [Abstract][Full Text] [Related]
7. Experimentally induced psoriatic lesion associates with interleukin (IL)-6 in mast cells and appearance of dermal cells expressing IL-33 and IL-6 receptor.
Suttle MM; Nilsson G; Snellman E; Harvima IT
Clin Exp Immunol; 2012 Sep; 169(3):311-9. PubMed ID: 22861371
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric assessment of clearance and relapse characteristics in psoriasis vulgaris after treatment with weekly clobetasol lotion under hydrocolloid occlusion versus twice-daily clobetasol ointment.
Glade CP; van der Vleuten CJ; van Erp PE; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2002; 15(2):92-9. PubMed ID: 11867965
[TBL] [Abstract][Full Text] [Related]
9. Photofibrosis: a further histopathological change induced by PUVA therapy via the mast cell in guttate psoriasis. Preliminary report.
Borroni G; Vignati G; Zaccone C; Gorani A; Brazzelli V; Rabbiosi G
Acta Derm Venereol Suppl (Stockh); 1994; 186():159-61. PubMed ID: 8073822
[TBL] [Abstract][Full Text] [Related]
10. Mast cell degranulation in the evolution of acute eruptive guttate psoriasis vulgaris.
Brody I
J Invest Dermatol; 1984 May; 82(5):460-4. PubMed ID: 6512269
[TBL] [Abstract][Full Text] [Related]
11. A clinical and flow cytometric model to study remission and relapse in psoriasis.
Glade CP; van Erp PE; Werner-Schlenzka H; van de Kerkhof PC
Acta Derm Venereol; 1998 May; 78(3):180-5. PubMed ID: 9602222
[TBL] [Abstract][Full Text] [Related]
12. Mast cells in the initial stages of psoriasis.
Toruniowa B; Jabłońska S
Arch Dermatol Res; 1988; 280(4):189-93. PubMed ID: 3233011
[TBL] [Abstract][Full Text] [Related]
13. Clobetasol under hydrocolloid occlusion in psoriasis results in a complete block of proliferation and in a rebound of lesions following discontinuation.
Mommers JM; van Erp PE; van De Kerkhof PC
Dermatology; 1999; 199(4):323-7. PubMed ID: 10640842
[TBL] [Abstract][Full Text] [Related]
14. Clinical and histologic heterogeneity of psoriatic plaques. Therapeutic relevance.
Griffin TD; Lattanand A; VanScott EJ
Arch Dermatol; 1988 Feb; 124(2):216-20. PubMed ID: 3341801
[TBL] [Abstract][Full Text] [Related]
15. Clobetasol propionate spray 0.05% for the treatment of moderate to severe plaque psoriasis.
Menter A
Cutis; 2012 Feb; 89(2):89-94. PubMed ID: 22474733
[TBL] [Abstract][Full Text] [Related]
16. Morphologically distinctive forms of cutaneous mast cell degranulation induced by cold and mechanical stimuli: an ultrastructural study.
Murphy GF; Austen KF; Fonferko E; Sheffer AL
J Allergy Clin Immunol; 1987 Oct; 80(4):603-11. PubMed ID: 3668125
[TBL] [Abstract][Full Text] [Related]
17. VML 295 (LY-293111), a novel LTB4 antagonist, is not effective in the prevention of relapse in psoriasis.
Mommers JM; Van Rossum MM; Kooijmans-Otero ME; Parker GL; van de Kerkhof PC
Br J Dermatol; 2000 Feb; 142(2):259-66. PubMed ID: 10730758
[TBL] [Abstract][Full Text] [Related]
18. Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis.
Poulin Y; Papp K; Bissonnette R; Guenther L; Tan J; Lynde C; Kerrouche N; Villemagne H;
Cutis; 2010 Jan; 85(1):43-50. PubMed ID: 20184211
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for mast cells in psoriasis?
Harvima IT; Nilsson G; Suttle MM; Naukkarinen A
Arch Dermatol Res; 2008 Oct; 300(9):461-78. PubMed ID: 18719932
[TBL] [Abstract][Full Text] [Related]
20. Granule changes of human skin mast cells characteristic of piecemeal degranulation and associated with recovery during wound healing in situ.
Dvorak AM; Kissell S
J Leukoc Biol; 1991 Feb; 49(2):197-210. PubMed ID: 1992000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
